Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2025 11:25 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology

Groundbreaking Study Demonstrates Safety and Tolerability of Oral Mucosal Immunotherapy (OMIT) for Peanut Allergy Using Toothpaste
February 06, 2024 09:34 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

New study is the first to evaluate Oral Mucosal Immunotherapy (OMIT) for the treatment of food allergy
March 12, 2021 09:30 ET | Source: Intrommune Therapeutics

Research Presentations at the 2021 Annual AAAAI Meeting Highlight Limitations of Current Food Allergy Treatments and Further Validates Intrommune Therapeutics’ Approach

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- The clinical and scientific team of Intrommune Therapeutics, a New York-based clinical stage biotechnology company developing patient-friendly treatments...
March 02, 2018 08:00 ET | Source: asthma & allergy friendly Certification Program

The asthma & allergy friendly® Certification Program Showcases Its Certified Products and Services to Thousands of Allergist, Immunologists, and Healthcare Professionals from Around the World

WASHINGTON, DC., March 02, 2018 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) announced today that the asthma & allergy friendly®...